Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Drug Resistance

  Free Subscription

Articles published in PLoS Comput Biol

Retrieve available abstracts of 14 articles:
HTML format
Text format

Single Articles

    January 2017
  1. ABEL ZUR WIESCH P, Clarelli F, Cohen T
    Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies.
    PLoS Comput Biol. 2017;13:e1005321.
    PubMed     Text format     Abstract available

  2. ROSSI NA, Dunlop MJ
    Customized Regulation of Diverse Stress Response Genes by the Multiple Antibiotic Resistance Activator MarA.
    PLoS Comput Biol. 2017;13:e1005310.
    PubMed     Text format     Abstract available

    June 2016
  3. LEE D, Das S, Dawson NL, Dobrijevic D, et al
    Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases.
    PLoS Comput Biol. 2016;12:e1004926.
    PubMed     Text format     Abstract available

    May 2016
  4. RAST LI, Rouzine IM, Rozhnova G, Bishop L, et al
    Conflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing Resistance-Proof Antivirals.
    PLoS Comput Biol. 2016;12:e1004799.
    PubMed     Text format     Abstract available

    April 2016
  5. GJINI E, Brito PH
    Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.
    PLoS Comput Biol. 2016;12:e1004857.
    PubMed     Text format     Abstract available

    March 2016
  6. JACOBS M, Gregoire N, Couet W, Bulitta JB, et al
    Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling.
    PLoS Comput Biol. 2016;12:e1004782.
    PubMed     Text format     Abstract available

    January 2016
  7. WEE KB, Lee RT, Lin J, Pramono ZA, et al
    Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance.
    PLoS Comput Biol. 2016;12:e1004663.
    PubMed     Text format     Abstract available

    June 2015
  8. OBOLSKI U, Stein GY, Hadany L
    Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.
    PLoS Comput Biol. 2015;11:e1004340.
    PubMed     Text format     Abstract available

  9. KE R, Loverdo C, Qi H, Sun R, et al
    Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection.
    PLoS Comput Biol. 2015;11:e1004040.
    PubMed     Text format     Abstract available

    April 2015
  10. MEREDITH HR, Lopatkin AJ, Anderson DJ, You L, et al
    Bacterial temporal dynamics enable optimal design of antibiotic treatment.
    PLoS Comput Biol. 2015;11:e1004201.
    PubMed     Text format     Abstract available

  11. FLYNN WF, Chang MW, Tan Z, Oliveira G, et al
    Deep Sequencing of Protease Inhibitor Resistant HIV Patient Isolates Reveals Patterns of Correlated Mutations in Gag and Protease.
    PLoS Comput Biol. 2015;11:e1004249.
    PubMed     Text format     Abstract available

    March 2015
  12. MIGUEL A, Hsin J, Liu T, Tang G, et al
    Variations in the binding pocket of an inhibitor of the bacterial division protein FtsZ across genotypes and species.
    PLoS Comput Biol. 2015;11:e1004117.
    PubMed     Text format     Abstract available

    November 2014
  13. GOPALAKRISHNAN S, Montazeri H, Menz S, Beerenwinkel N, et al
    Estimating HIV-1 Fitness Characteristics from Cross-Sectional Genotype Data.
    PLoS Comput Biol. 2014;10:e1003886.
    PubMed     Text format     Abstract available

    September 2014
  14. HEPLER NL, Scheffler K, Weaver S, Murrell B, et al
    IDEPI: Rapid Prediction of HIV-1 Antibody Epitopes and Other Phenotypic Features from Sequence Data Using a Flexible Machine Learning Platform.
    PLoS Comput Biol. 2014;10:e1003842.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.